Treatment of Group B Streptococcus Urinary Tract Infection
For Group B Streptococcus (GBS) urinary tract infections, treat with penicillin or ampicillin as first-line therapy, as all GBS strains remain universally susceptible to these agents.
First-Line Antibiotic Selection
Penicillin and ampicillin are the preferred agents for GBS UTI treatment based on universal susceptibility patterns 1. All GBS isolates demonstrate 100% sensitivity to penicillin, ampicillin, and vancomycin, making these the most reliable therapeutic options 1.
Recommended Regimens:
- Ampicillin: Standard oral dosing for uncomplicated UTI (typically 500 mg four times daily) 2
- Penicillin: Alternative first-line option with equivalent efficacy 2
- Treatment duration: 7-14 days depending on clinical severity and patient sex (14 days for males when prostatitis cannot be excluded) 3
Alternative Agents for Penicillin Allergy
For patients with documented penicillin allergy, alternative options include 1, 2:
- Vancomycin: 100% susceptibility, reserved for severe penicillin allergy 1
- Cephalosporins (cephalothin): >95% sensitivity 2
- Avoid clindamycin and tetracycline: High resistance rates (77% and 88% respectively) make these poor choices 1
Critical Clinical Considerations
Pregnancy-Specific Management
Women with GBS bacteriuria at ANY colony count during pregnancy require intrapartum antibiotic prophylaxis, not just treatment of the UTI itself 4, 5. This is a crucial distinction:
- Treat symptomatic UTI or colony counts ≥100,000 CFU/mL at time of diagnosis 5
- All pregnant women with documented GBS bacteriuria (regardless of CFU count) must receive intravenous antibiotics during labor to prevent early-onset neonatal GBS disease 4, 5
- Do not re-screen these women in the third trimester—they are presumed GBS colonized 5
Non-Pregnant Adults
GBS accounts for approximately 2% of UTIs in non-pregnant adults and signals the need for urological evaluation 6:
- Screen for urinary tract abnormalities: 60% of patients have underlying structural problems 6
- Assess for chronic renal failure: Present in 27% of cases 6
- Clinical manifestations equally affect upper and lower urinary tract (37% vs 38%) 6
- Poor clinical outcomes occur in 18% despite treatment, emphasizing need for thorough evaluation 6
Identification of Infection Reservoirs
Successful treatment requires identifying and addressing all GBS reservoirs 2:
- Vaginal colonization in women
- Urethral colonization in men
- Gastrointestinal tract colonization
For women with concurrent vaginal colonization, consider local treatment with vaginal lavages using 2% chlorhexidine solution in addition to systemic antibiotics 2.
Common Pitfalls to Avoid
Do NOT treat asymptomatic GBS colonization outside of pregnancy 4. Antimicrobial treatment before the intrapartum period is ineffective in eliminating carriage, does not prevent neonatal disease, and may cause adverse consequences including antibiotic resistance 4.
Do NOT use erythromycin or clindamycin empirically given resistance rates of 36% and 26% respectively 1. Recent evidence suggests erythromycin exposure may paradoxically protect MDR GBS against oxidative stress, potentially complicating treatment 7.
Patient Demographics at Higher Risk
Women aged 25-34 years show increased likelihood of GBS UTI compared to younger women (OR 1.91) 1. Diabetes mellitus significantly increases risk for invasive GBS urogenital infections in both pregnant and non-pregnant patients 8.